Exhibit 10.1
AMENDMENT
TO THE
AGREEMENT AND PLAN OF
MERGER
Amendment, dated as of
January 7, 2009 (this “ Amendment
”), to the Agreement and Plan of Merger (the “
Agreement ”), dated as of January 5, 2009,
by and among Endo Pharmaceuticals Holdings Inc., a Delaware
corporation (“ Parent ”), BTB Purchaser
Inc., a Delaware corporation and a direct, wholly-owned Subsidiary
of Parent (“ Merger Sub ”), and Indevus
Pharmaceuticals, Inc., a Delaware corporation (the “
Company ”).
W I T N E S
S E T H :
WHEREAS, in accordance with
Section 8.3 of the Agreement, Parent, Merger Sub and the
Company wish to amend the terms of the Agreement as provided in
Section I below;
WHEREAS, unless otherwise defined
herein, capitalized terms used but not defined herein shall have
the meanings assigned to them in the Agreement;
NOW, THEREFORE, in consideration of
the premises and for other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the
parties hereto agree as follows:
SECTION I
AMENDMENT
The first sentence of
Section 1.1(a)(i) of the Agreement is hereby deleted and
re